Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma

doi:10.3748/wjg.14.3879

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 24

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2926)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

339

HTML

2274

Figures (1-1)

151

Tables (1-2)

162

Sum=2926

Jun 28, 2008 (publication date) through Nov 9, 2024

Times Cited of This Article

Times Cited (31)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jun 28, 2008; 14(24): 3879-3883
Published online Jun 28, 2008. doi: 10.3748/wjg.14.3879

Table 1 Serum concentrations (pg/mL) of VEGF-A, -C, and -D, and VEGFR-1 and -2 in patients with gastric adenocarcinoma and control subjects (n=76)

	Patients	Control	P
VEGF-A	585.7 ± 408.4;	444.9 ± 328.9;	0.02
	469.3¹ (44.1-1927.7)	346.9 (31.1-630.6)
VEGF-C	6141.0 ± 2456.1;	6067.8 ± 2219.3;	0.88
	5858.4¹ (970.4-12 158.9)	5872.3 (711.7-12 158.9)
VEGF-D	483.0 ± 259.3;	671.1 ± 501.8;	0.004
	428.9¹ (205.7-1355.2)	605.9 (205.7-3859.7)
VEGFR-1	873.7 ± 360.8;	645.3 ± 297.9;	0.0001
	1026.4¹ (279.4-1767.6)	475.4 (224.1-1333.6)
VEGFR-2	9266.5 ± 2 111.1;	9420.3 ± 1840.7;	0.45
	9382.3¹ (4726.1-15 427.3)	9386.2 ( 5727.9-15 433.3)

¹Refers to mean ± SD; median (range).

Table 2 Associations between serum concentrations (pg/mL) of VEGF-A, -C, and -D, and VEGFR-1 and -2 and clinco-pathological features in 76 patients of gastric adenocarcinoma and 76 control subjects (mean ± SD )

Pathological	n	VEGF-A	VEGF-C	VEGF-D	VEGFR-1	VEGFR-2
Site
Distal	43	522.9 ± 371.6	6035.5 ± 2544.3	474.1 ± 276.5	863.0 ± 380.3	9058.9 ± 2140.2
Non-distal	33	667.5 ± 444.4	6278.5 ± 2368.0	494.6 ± 238.6	887.7 ± 341.7	9537.0 ± 2073.7
Classification
Intestinal	40	586.0 ± 381.1	5895.3 ±2315.7	472.3 ± 216.9	872.8 ± 361.7	8982.6 ± 2408.5
Diffuse or mixed	36	585.5 ± 436.4	6362.2 ± 2585.0	492.6 ± 367.2	874.6 ± 366.7	9522.0 ± 1795.4
T stage+
T1 + T2	12	635.6 ± 291.3	4843.4 ± 1682.9	465.3 ± 248.0	661.4 ± 383.3	8144.9 ± 1804.8
T3 + T4	46	484.1 ± 377.1	6378.0 ± 2345.8^a	501.9 ± 286.4	872.3 ± 364.6	9344.9 ± 2254.5
Lymph node+
Negative	8	597.4 ± 476.5	5450.7 ± 2381.5	397.3 ± 116.9	717.5 ± 364.9	8843.8 ± 2419.8
Positive	50	503.2 ± 346.2	6065.6 ± 2367.4	514.1 ± 291.8	828.8 ± 377.8	9065.2 ± 2076.8
Metastasis
Absent	42	517.0 ± 331.5	5918.8 ± 2456.4	493.4 ± 283.9	779.1 ± 396.5	9007.8 ± 2297.8
Present	34	670.5 ±478.8	6415.5 ± 2464.3	470.1 ± 228.8	990.7 ± 277.1^a	9586.1 ± 1838.1
Stage
1 + 2	13	586.5 ± 400.1	4848.8 ± 1948.7	458.6 ± 225.1	633.1 ± 365.1	8785.6 ± 2082.9
3 + 4	63	585.5 ± 413.3	6407.7 ± 2477.9^a	488.1 ± 267.1	923.4 ± 343.4^b	9365.8 ± 2119.7
Differentiation
Well	6	335.9 ± 310.5	4386.9 ± 2653.1	363.3 ± 102.0	595.5 ± 341.1	7265.1 ± 2188.0
Moderate + poor	70	607.1 ± 410.4	6291.4 ± 2399.2	493.3 ± 266.4	897.6 ± 355.8^a	9438.1 ± 2029.6^a

^aP < 0.05 and

^bP < 0.01 vs determined in patients who had surgical resections (n = 58).

Citation: Al-Moundhri MS, Al-Shukaili A, Al-Nabhani M, Al-Bahrani B, Burney I, Rizivi A, Ganguly S. Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma. World J Gastroenterol 2008; 14(24): 3879-3883
URL: https://www.wjgnet.com/1007-9327/full/v14/i24/3879.htm
DOI: https://dx.doi.org/10.3748/wjg.14.3879